Literature DB >> 10601655

Uptake of [(3)H]bilirubin in freshly isolated rat hepatocytes: role of free bilirubin concentration.

M G Mediavilla1, L Pascolo, J V Rodriguez, E E Guibert, J D Ostrow, C Tiribelli.   

Abstract

Hepatocytic transport of physiological concentrations of unconjugated bilirubin (UCB) has not been determined in isolated liver cells. Initial uptake of highly purified [(3)H]UCB was measured in rat hepatocytes in the presence of human serum albumin at various free, unbound UCB concentrations, [UCB]. At [UCB]=42 nM (below aqueous solubility of 70 nM), uptake was strictly temperature dependent; this was much less evident at [UCB]=166 nM (supersaturated). At low, physiological UCB concentrations, specific UCB uptake showed saturative kinetics with an apparent K(m) of 41 nM, indicating carrier-mediated transport. With aqueous supersaturation, UCB entered hepatocytes mainly by passive diffusion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10601655     DOI: 10.1016/s0014-5793(99)01606-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Bilirubin-a potential marker of drug exposure in atazanavir-based antiretroviral therapy.

Authors:  Dinko Rekić; Oskar Clewe; Daniel Röshammar; Leo Flamholc; Anders Sönnerborg; Vidar Ormaasen; Magnus Gisslén; Angela Abelö; Michael Ashton
Journal:  AAPS J       Date:  2011-09-13       Impact factor: 4.009

2.  Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by bilirubin at the blood-CSF and blood-brain barriers in the Gunn rat.

Authors:  Silvia Gazzin; Andrea Lorena Berengeno; Nathalie Strazielle; Francesco Fazzari; Alan Raseni; J Donald Ostrow; Richard Wennberg; Jean-François Ghersi-Egea; Claudio Tiribelli
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

3.  Bile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress.

Authors:  Lucie Muchova; Katerina Vanova; Jaroslav Zelenka; Martin Lenicek; Tomas Petr; Martin Vejrazka; Eva Sticova; Hendrik Jan Vreman; Ronald James Wong; Libor Vitek
Journal:  J Cell Mol Med       Date:  2010-05-28       Impact factor: 5.310

4.  Atazanavir-bilirubin interaction: a pharmacokinetic-pharmacodynamic model.

Authors:  Roberto Lozano; Nieves Domeque; Alberto-Fermin Apesteguia
Journal:  Clin Pharmacol       Date:  2013-09-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.